Dynamic Technology Lab Private Ltd Has $564,000 Stock Holdings in VAREX IMAGING $VREX

Key Points

• Dynamic Technology Lab Private Ltd increased its stake in VAREX IMAGING by 260.6% in the first quarter, owning 48,628 shares valued at $564,000.
• VAREX IMAGING recently reported earnings of $0.18 per share, surpassing analysts' expectations of $0.04, with a revenue of $203 million for the quarter.
• Wall Street analysts have mixed reviews on the stock, with a consensus rating of "Buy" and a price target of $19.50, though one analyst downgraded it from "strong-buy" to "buy."

Dynamic Technology Lab Private Ltd increased its position in shares of VAREX IMAGING (NASDAQ:VREX - Free Report) by 260.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 48,628 shares of the company's stock after acquiring an additional 35,144 shares during the quarter. Dynamic Technology Lab Private Ltd owned about 0.12% of VAREX IMAGING worth $564,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Point72 Hong Kong Ltd acquired a new stake in VAREX IMAGING in the fourth quarter worth $48,000. Quarry LP acquired a new stake in VAREX IMAGING during the 1st quarter worth $63,000. Zurcher Kantonalbank Zurich Cantonalbank lifted its holdings in VAREX IMAGING by 58.0% during the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,279 shares of the company's stock worth $131,000 after acquiring an additional 4,139 shares in the last quarter. ProShare Advisors LLC bought a new position in VAREX IMAGING during the fourth quarter worth about $159,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in VAREX IMAGING in the first quarter valued at about $160,000.

Wall Street Analyst Weigh In

VREX has been the topic of a number of research analyst reports. Wall Street Zen lowered VAREX IMAGING from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 9th. B. Riley reaffirmed a "buy" rating and issued a $16.00 price target (up previously from $12.00) on shares of VAREX IMAGING in a research note on Friday, August 8th. Two analysts have rated the stock with a Buy rating, According to MarketBeat, the stock has a consensus rating of "Buy" and a consensus price target of $19.50.

VAREX IMAGING Stock Down 5.4%

NASDAQ:VREX opened at $10.96 on Thursday. The stock has a 50-day simple moving average of $9.40 and a 200 day simple moving average of $9.38. VAREX IMAGING has a 52-week low of $6.76 and a 52-week high of $16.93. The company has a market cap of $454.84 million, a PE ratio of -3.41 and a beta of 0.87. The company has a debt-to-equity ratio of 0.78, a quick ratio of 1.82 and a current ratio of 3.51.

VAREX IMAGING (NASDAQ:VREX - Get Free Report) last released its quarterly earnings results on Thursday, August 7th. The company reported $0.18 earnings per share for the quarter, topping analysts' consensus estimates of $0.04 by $0.14. The firm had revenue of $203.00 million during the quarter, compared to the consensus estimate of $190.32 million. VAREX IMAGING had a positive return on equity of 5.54% and a negative net margin of 16.13%. VAREX IMAGING has set its Q4 2025 guidance at 0.100-0.300 EPS. On average, sell-side analysts expect that VAREX IMAGING will post 0.53 EPS for the current fiscal year.

VAREX IMAGING Profile

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.